Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Clinical trial NCT00916409 · COMPLETED

Trial details

NCT number: NCT00916409
Sponsor: NovoCure Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2009-06-01
Primary completion: 2016-12-01
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.